Shares of Chinese battery giant Contemporary Amperex Technology (CATL) surged as much as 3.43% on the Shenzhen Exchange on ...

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

Zhen and Winni Zhou HONG KONG/SHANGHAI (Reuters) -Hong Kong dollar rates fell across the board on Friday, heading for their ...

The Hong Kong dollar tested the strong end of its allowable trading band for a second session Monday, as regional currencies ...

Expert says ‘recent weaknesses in the Hong Kong dollar against other regional currencies’ could help to sustain growth in ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

Hong Kong intervened to defend its peg, buying a record amount of US dollars after the city’s currency rose to the upper end ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Hong Kong's de-facto central bank said it sold HK$46.54 billion ($6 billion) into the market on Saturday to prevent the local ...

Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.